To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:
Get updates on our training programs, scientific openings, and latest research findings on Twitter.
The following are highlighted research findings and scientific papers by DCEG investigators.
January 24, 2019
CHEK2 germline pathogenic variants are associated with a four-to-six times elevated risk for Testicular Germ Cell Tumors (TGCT), and an average age at presentation six years earlier than carriers of wild-type alleles.
January 16, 2019
Researchers in the NCI Division of Cancer Epidemiology and Genetics and collaborators at the National Institutes of Health conducted a formal analysis of overall death rates and death rates from drug poisoning among 25-64-year-olds in the United States. They compared rates across race/ethnicity, socioeconomic status, rurality and geography to determine whether increases in these deaths are limited to poor, rural, white communities in regions with high unemployment.
January 10, 2019
A research team led by investigators from NIH and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
January 09, 2019
BRCA Exchange is a global resource with data and expert classification on thousands of inherited variants in the BRCA1 and BRCA2 genes that will improve cancer prevention, screening, and intervention for high-risk patients.
January 04, 2019
HPV screening history of multiple negative HPV and cytology cotests important for management of current results in cervical cancer screening programs. The data come from over a million women aged 30 and older in Kaiser Permanente Northern California.
December 31, 2018
Findings from a new study by researchers at the National Cancer Institute (NCI) show that patients treated with chemotherapy for most solid tumors experienced an increased risk of myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML).